Prime Medicine, Inc. (PRME), a developer of a new class of differentiated one-time curative genetic therapies, said on Thursday that it has appointed Svetlana Makhni as Chief Financial Officer.
Prior to joining Prime Medicine, Makhni served as CFO of Marengo Therapeutics, a clinical-stage immuno-oncology company. Previously, she worked as CFO of Escient Pharmaceuticals and CFO and Head of Operations at Bierman ABA.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.